China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through four segments: Humankind, HLJ Huimeijia, HempCan, and Others segments. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.
Frequently asked questions
What sector does China Health Industries Holdings Inc (CHHE) operate in?
China Health Industries Holdings Inc belongs to the Consumer Staples sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is China Health Industries Holdings Inc (CHHE) current stock price?
As of the latest data, China Health Industries Holdings Inc stock price is $0.00, with a previous close of $0.00.
What is China Health Industries Holdings Inc (CHHE) current market capitalization?
China Health Industries Holdings Inc market cap is approximately 6.55 thousand.
Does China Health Industries Holdings Inc (CHHE) pay dividends?
No. China Health Industries Holdings Inc does not pay a dividend.
What is China Health Industries Holdings Inc (CHHE) beta (volatility) score?
China Health Industries Holdings Inc has a beta of -20.885, indicating lower volatility than the overall market.